The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment

Objective:  The objective of the European Schizophrenia Outpatient Health Outcomes (SOHO) study is to understand the comparative costs and outcomes of antipsychotic drug treatment, with specific focus on olanzapine. The study will also provide a large database for research into the treatment and out...

Full description

Saved in:
Bibliographic Details
Published in:Acta psychiatrica Scandinavica 2003-03, Vol.107 (3), p.222-232
Main Authors: Haro, J. M., Edgell, E. T., Jones, P. B., Alonso, J., Gavart, S., Gregor, K. J., Wright, P., Knapp, M.
Format: Article
Language:English
Subjects:
Activities of Daily Living
antipsychotic agents
Antipsychotic Agents - economics
Antipsychotic Agents - therapeutic use
Benzodiazepines
Biological and medical sciences
epidemiologic research design
Europe
Humans
longitudinal studies
Medical sciences
Mental health
multicentre studies
Olanzapine
Organization of mental health. Health systems
Outpatients - statistics & numerical data
Pirenzepine - analogs & derivatives
Pirenzepine - economics
Pirenzepine - therapeutic use
Prospective Studies
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Quality of Life
schizophrenia
Schizophrenia - drug therapy
Schizophrenia - economics
Schizophrenic Psychology
Social Behavior
Social psychiatry. Ethnopsychiatry
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective:  The objective of the European Schizophrenia Outpatient Health Outcomes (SOHO) study is to understand the comparative costs and outcomes of antipsychotic drug treatment, with specific focus on olanzapine. The study will also provide a large database for research into the treatment and outcome of schizophrenia. The role of observational studies in the assessment of the effectiveness of antipsychotic agents is reviewed, and the rationale, design and recruitment issues surrounding the SOHO study are presented. Method:  SOHO is a 3‐year, prospective, observational study of the health outcomes associated with antipsychotic treatment in Europe. Results:  Over 10 000 patients have been recruited from 10 countries. Baseline evaluation included measures of clinical status, social functioning, quality of life, service use and pharmacological treatment. Patients will be followed for 3 years. Conclusion:  The SOHO study will complement randomized controlled trial findings on the treatment of schizophrenia and will address relevant clinical and policy research questions.
ISSN:0001-690X
1600-0447
DOI:10.1034/j.1600-0447.2003.00064.x